Malaria Journal Impact Factor 2024-2025 - ResearchHelpDesk - Aims and scope Malaria Journal is aimed at the scientific community interested in malaria in its broadest sense. It is the only journal that publishes exclusively articles on malaria and, as such, it aims to bring together knowledge from the different specialities involved in this very broad discipline, from the bench to the bedside and to the field. Open access All articles published by Malaria Journal are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers. Further information about open access can be found here. As authors of articles published in Malaria Journal you are the copyright holders of your article and have granted to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate your article, according to the BMC license agreement. For those of you who are US government employees or are prevented from being copyright holders for similar reasons, BMC can accommodate non-standard copyright lines. Please contact us if further information is needed. Article-processing charges Open access publishing is not without costs. Malaria Journal therefore levies an article-processing charge of £1790.00/$2490.00/€2090.00 for each article accepted for publication, plus VAT or local taxes where applicable. If the corresponding author's institution participates in our open access membership program, some or all of the publication cost may be covered (more details available on the membership page). We routinely waive charges for authors from low-income countries. For other countries, article-processing charge waivers or discounts are granted on a case-by-case basis to authors with insufficient funds. Authors can request a waiver or discount during the submission process. For further details, see our article-processing charge page. Visit Springer Nature’s open access funding & support services for information about research funders and institutions that provide funding for APCs. Springer Nature offers agreements that enable institutions to cover open access publishing costs. Learn more about our open access agreements to check your eligibility and discover whether this journal is included. For more information on APCs please see our Journal Pricing FAQs Indexing services All articles published in Malaria Journal are included in: CABI CAS Citebase Current contents DOAJ Embase Global Health MEDLINE OAIster PubMed PubMed Central Science Citation Index Science Citation Index Expanded SCImago Scopus SOCOLAR Zetoc Zoological Record

Journal of Ophthalmology Impact Factor 2024-2025 - ResearchHelpDesk - Journal of Ophthalmology is a peer-reviewed, Open Access journal that publishes original research, review, and clinical studies related to the anatomy, physiology and diseases of the eye. Submissions should focus on focusing on new diagnostic and surgical techniques, instrument and therapy updates, as well as clinical trials and research findings. Journal of Ophthalmology is archived in Portico, which provides permanent archiving for electronic scholarly journals, as well as via the LOCKSS initiative. It operates a fully open access publishing model which allows open global access to its published content. This model is supported through Article Processing Charges. The most recent Impact Factor for Journal of Ophthalmology is 1.580 according to the 2018 Journal Citation Reports released by Clarivate Analytics in 2019. The journal’s most recent CiteScore is 1.78 according to the CiteScore 2018 metrics released by Scopus. Journal of Ophthalmology is included in many leading abstracting and indexing databases. Academic OneFile Academic Search Alumni Edition Academic Search Complete Airiti Library Biological Sciences Chemical Abstracts Service (CAS) CINAHL Plus with Full Text CNKI Scholar Directory of Open Access Journals (DOAJ) EBSCO Discovery Service EBSCOhost Connection EBSCOhost Research Databases Expanded Academic ASAP Expanded Academic Index Google Scholar Health and Wellness Resource Center Health Reference Center Academic HINARI Access to Research in Health Programme InfoTrac Custom journals J-Gate Portal Journal Citation Reports - Science Edition Open Access Journals Integrated Service System Project (GoOA) Primo Central Index PubMed PubMed Central SafetyLit Science Citation Index Expanded Scopus The Summon Service WorldCat Discovery Services

Indian journal of public health Impact Factor 2024-2025 - ResearchHelpDesk - Indian Journal of Public Health is a peer-reviewed international journal published Quarterly by the Indian Public Health Association. It is indexed/abstracted by the major international indexing systems like Index Medicus/MEDLINE, SCOPUS, PUBMED, etc. The journal allows free access (Open Access) to its contents and permits authors to self-archive the final accepted version of the articles. The journal’s full text is available online at www.ijph.in. Abstracting and Indexing Information The journal is registered with the following abstracting partners: Baidu Scholar, CNKI (China National Knowledge Infrastructure), EBSCO Publishing's Electronic Databases, Ex Libris – Primo Central, Google Scholar, Hinari, Infotrieve, National Science Library, ProQuest, TdNet, Wanfang Data The journal is indexed with, or included in, the following: DOAJ, Emerging Sources Citation Index, Indian Science Abstracts, IndMed, MEDLINE/Index Medicus, Scimago Journal Ranking, SCOPUS, Web of Science

Inspied by this post on biostar: http://www.biostars.org/post/show/54473/calculating-time-from-submission-to-publication-degree-of-burden-in-submitting-a-paper/ initialy asked by Ryan Delahanty

the script 'pubmed.sh" downloads the the journals from http://www.ncbi.nlm.nih.gov/books/NBK3827/table/pubmedhelp.pubmedhelptable45/ , the 'eignefactors' from http://www.eigenfactor.org for each journal , It scans pubmed (starting from year=2000) and get the difference between the date(submitted) and the date(accepted). The code for the java program used to download pubmed is available here: https://github.com/lindenb/jsandbox/blob/master/src/sandbox/PubmedDump.java

Note: pubmed contains some errors: e.g. submitted > accepted (http://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=20591334&retmode=xml) or some dates in the future: ( http://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=12921703&retmode=xml )

Unlock valuable biomedical knowledge with our comprehensive PubMed Dataset, designed for researchers, analysts, and healthcare professionals to track medical advancements, explore drug discoveries, and analyze scientific literature.

Dataset Features

Scientific Articles & Abstracts: Access structured data from PubMed, including article titles, abstracts, authors, publication dates, and journal sources. Medical Research & Clinical Studies: Retrieve data on clinical trials, drug research, disease studies, and healthcare innovations. Keywords & MeSH Terms: Extract key medical subject headings (MeSH) and keywords to categorize and analyze research topics. Publication & Citation Data: Track citation counts, journal impact factors, and author affiliations for academic and industry research.

Customizable Subsets for Specific Needs Our PubMed Dataset is fully customizable, allowing you to filter data based on publication date, research category, keywords, or specific journals. Whether you need broad coverage for medical research or focused data for pharmaceutical analysis, we tailor the dataset to your needs.

Popular Use Cases

Pharmaceutical Research & Drug Development: Analyze clinical trial data, drug efficacy studies, and emerging treatments. Medical & Healthcare Intelligence: Track disease outbreaks, healthcare trends, and advancements in medical technology. AI & Machine Learning Applications: Use structured biomedical data to train AI models for predictive analytics, medical diagnosis, and literature summarization. Academic & Scientific Research: Access a vast collection of peer-reviewed studies for literature reviews, meta-analyses, and academic publishing. Regulatory & Compliance Monitoring: Stay updated on medical regulations, FDA approvals, and healthcare policy changes.

Whether you're conducting medical research, analyzing healthcare trends, or developing AI-driven solutions, our PubMed Dataset provides the structured data you need. Get started today and customize your dataset to fit your research objectives.

Top 20 journals that published acupuncture articles over the 20 year period, 1995–2014.

International Journal of Womens Health Impact Factor 2024-2025 - ResearchHelpDesk - The International Journal of Women's Health (ISSN: 1179-1411) is a peer-reviewed healthcare journal focusing on all aspects of women's health care, including gynecology, obstetrics, and breast cancer. Abstracted &Indexing Details: PubMed and PubMed Central (Int J Womens Health) Emerging Sources Citation Index (ESCI), from 2016 Embase, from 2009 (Correct as at December 8, 2016) Scopus, from 2009 (Correct as at December 8, 2016) OAIster - The Open Access Initiative Directory of Open Access Journals (DOAJ) The journal is published by Dove Medical Press.

Acupuncture publications in PubMed for 5-year intervals between 1995 and 2014.

Citations identified via PubMed during 1995–2014. (7Z)

List of the fifty general internal medicine journals included in the study, with their 2020 impact factor (according to Journal Citation Reports).

Public Health Reports Impact Factor 2024-2025 - ResearchHelpDesk - Public Health Reports is the official journal of the Office of the U.S. Surgeon General and the U.S. Public Health Service and has been published since 1878. It is published bimonthly, plus supplement issues, through an official agreement with the Association of Schools and Programs of Public Health. The journal is peer-reviewed and publishes original research, reviews, and commentaries in the areas of public health practice and methodology, public health law, and teaching at schools and programs of public health. Issues contain regular commentaries by the U.S. Surgeon General and executives of the U.S. Department of Health and Human Services and the Office of the Assistant Secretary of Health. The journal focuses upon such topics as tobacco control, teenage violence, occupational disease and injury, immunization, drug policy, lead screening, health disparities, and many other key and emerging public health issues. In addition to the six regular issues, PHR produces supplemental issues approximately 2-5 times per year which focus on specific topics that are of particular interest to our readership. The journal's contributors are on the front line of public health and they present their work in a readable and accessible format. Abstract & indexing Clarivate Analytics: Current Contents - Clinical Medicine Clarivate Analytics: Science Citation Index (SCI) Clarivate Analytics: Social Sciences Citation Index (SSCI) Clarivate Analytics: Science Citation Index Expanded (SCIE) CABI: Global Health Clarivate Analytics: Current Contents - Social & Behavioral Sciences EBSCO EMBASE/Excerpta Medica Ovid JSTOR PubMed Central (PMC) PAIS International - ProQuest ProQuest Statistical Reference Index PubMed: MEDLINE Scopus

Update — December 7, 2014. – Evidence-based medicine (EBM) is not working for many reasons, for example: 1. Incorrect in their foundations (paradox): hierarchical levels of evidence are supported by opinions (i.e., lowest strength of evidence according to EBM) instead of real data collected from different types of study designs (i.e., evidence). http://dx.doi.org/10.6084/m9.figshare.1122534 2. The effect of criminal practices by pharmaceutical companies is only possible because of the complicity of others: healthcare systems, professional associations, governmental and academic institutions. Pharmaceutical companies also corrupt at the personal level, politicians and political parties are on their payroll, medical professionals seduced by different types of gifts in exchange of prescriptions (i.e., bribery) which very likely results in patients not receiving the proper treatment for their disease, many times there is no such thing: healthy persons not needing pharmacological treatments of any kind are constantly misdiagnosed and treated with unnecessary drugs. Some medical professionals are converted in K.O.L. which is only a puppet appearing on stage to spread lies to their peers, a person supposedly trained to improve the well-being of others, now deceits on behalf of pharmaceutical companies. Probably the saddest thing is that many honest doctors are being misled by these lies created by the rules of pharmaceutical marketing instead of scientific, medical, and ethical principles. Interpretation of EBM in this context was not anticipated by their creators. “The main reason we take so many drugs is that drug companies don’t sell drugs, they sell lies about drugs.” ―Peter C. Gøtzsche “doctors and their organisations should recognise that it is unethical to receive money that has been earned in part through crimes that have harmed those people whose interests doctors are expected to take care of. Many crimes would be impossible to carry out if doctors weren’t willing to participate in them.” —Peter C Gøtzsche, The BMJ, 2012, Big pharma often commits corporate crime, and this must be stopped. Pending (Colombia): Health Promoter Entities (In Spanish: EPS ―Empresas Promotoras de Salud).

1. Misinterpretations New technologies or concepts are difficult to understand in the beginning, it doesn’t matter their simplicity, we need to get used to new tools aimed to improve our professional practice. Probably the best explanation is here in these videos (credits to Antonio Villafaina for sharing these videos with me). English https://www.youtube.com/watch?v=pQHX-SjgQvQ&w=420&h=315 Spanish https://www.youtube.com/watch?v=DApozQBrlhU&w=420&h=315 ----------------------- Hypothesis: hierarchical levels of evidence based medicine are wrong Dear Editor, I have data to support the hypothesis described in the title of this letter. Before rejecting the null hypothesis I would like to ask the following open question:Could you support with data that hierarchical levels of evidence based medicine are correct? (1,2) Additional explanation to this question: – Only respond to this question attaching publicly available raw data.– Be aware that more than a question this is a challenge: I have data (i.e., evidence) which is contrary to classic (i.e., McMaster) or current (i.e., Oxford) hierarchical levels of evidence based medicine. An important part of this data (but not all) is publicly available. References
2. Ramirez, Jorge H (2014): The EBM challenge. figshare. http://dx.doi.org/10.6084/m9.figshare.1135873
3. The EBM Challenge Day 1: No Answers. Competing interests: I endorse the principles of open data in human biomedical research Read this letter on The BMJ – August 13, 2014.http://www.bmj.com/content/348/bmj.g3725/rr/762595Re: Greenhalgh T, et al. Evidence based medicine: a movement in crisis? BMJ 2014; 348: g3725. _ Fileset contents Raw data: Excel archive: Raw data, interactive figures, and PubMed search terms. Google Spreadsheet is also available (URL below the article description). Figure 1. Unadjusted (Fig 1A) and adjusted (Fig 1B) PubMed publication trends (01/01/1992 to 30/06/2014). Figure 2. Adjusted PubMed publication trends (07/01/2008 to 29/06/2014) Figure 3. Google search trends: Jan 2004 to Jun 2014 / 1-week periods. Figure 4. PubMed publication trends (1962-2013) systematic reviews and meta-analysis, clinical trials, and observational studies.
   Figure 5. Ramirez, Jorge H (2014): Infographics: Unpublished US phase 3 clinical trials (2002-2014) completed before Jan 2011 = 50.8%. figshare.http://dx.doi.org/10.6084/m9.figshare.1121675 Raw data: "13377 studies found for: Completed | Interventional Studies | Phase 3 | received from 01/01/2002 to 01/01/2014 | Worldwide". This database complies with the terms and conditions of ClinicalTrials.gov: http://clinicaltrials.gov/ct2/about-site/terms-conditions Supplementary Figures (S1-S6). PubMed publication delay in the indexation processes does not explain the descending trends in the scientific output of evidence-based medicine. Acknowledgments I would like to acknowledge the following persons for providing valuable concepts in data visualization and infographics:
4. Maria Fernanda Ramírez. Professor of graphic design. Universidad del Valle. Cali, Colombia.
5. Lorena Franco. Graphic design student. Universidad del Valle. Cali, Colombia. Related articles by this author (Jorge H. Ramírez)
6. Ramirez JH. Lack of transparency in clinical trials: a call for action. Colomb Med (Cali) 2013;44(4):243-6. URL: http://www.ncbi.nlm.nih.gov/pubmed/24892242
7. Ramirez JH. Re: Evidence based medicine is broken (17 June 2014). http://www.bmj.com/node/759181
8. Ramirez JH. Re: Global rules for global health: why we need an independent, impartial WHO (19 June 2014). http://www.bmj.com/node/759151
9. Ramirez JH. PubMed publication trends (1992 to 2014): evidence based medicine and clinical practice guidelines (04 July 2014). http://www.bmj.com/content/348/bmj.g3725/rr/759895 Recommended articles
10. Greenhalgh Trisha, Howick Jeremy,Maskrey Neal. Evidence based medicine: a movement in crisis? BMJ 2014;348:g3725
11. Spence Des. Evidence based medicine is broken BMJ 2014; 348:g22
12. Schünemann Holger J, Oxman Andrew D,Brozek Jan, Glasziou Paul, JaeschkeRoman, Vist Gunn E et al. Grading quality of evidence and strength of recommendations for diagnostic tests and strategies BMJ 2008; 336:1106
13. Lau Joseph, Ioannidis John P A, TerrinNorma, Schmid Christopher H, OlkinIngram. The case of the misleading funnel plot BMJ 2006; 333:597
14. Moynihan R, Henry D, Moons KGM (2014) Using Evidence to Combat Overdiagnosis and Overtreatment: Evaluating Treatments, Tests, and Disease Definitions in the Time of Too Much. PLoS Med 11(7): e1001655. doi:10.1371/journal.pmed.1001655
15. Katz D. A-holistic view of evidence based medicinehttp://thehealthcareblog.com/blog/2014/05/02/a-holistic-view-of-evidence-based-medicine/ ---

Background: Randomized control trials (RCTs) are considered the highest level of evidence for therapeutic research. Surgical RCTs, however, have drawbacks, leading some to question their role in filling the information gap in orthopaedic surgery. Pragmatism in study design was introduced to increase the clinical applicability of study results. However, there is a paucity of studies examining the effects of pragmatism on surgical RCTs. The purpose of this study was to examine how pragmatism affects the scholarly influence of surgical RCTs. Hip fracture surgical RCTs were used as an example. We hypothesized that a more pragmatic design would result in increased scholarly influence. Methods: A search for surgical hip fracture-related RCTs published between 1995-2015 was done in both PubMed and EMBASE. Journal impact factor, citation number, research question, significance and type of outcome, number of centers involved, and the PRECIS-2 level of pragmatism score were recorded for eac...

Top ranked countries with respect to numbers of acupuncture-related publications in the over the 20 year period, 1995–2014.

The impact of different journal submission requirements on report quality.

International journal of nursing studies Impact Factor 2024-2025 - ResearchHelpDesk - The International Journal of Nursing Studies (IJNS) provides a forum for original research and scholarship about health care delivery, organization, management, workforce, policy, and research methods relevant to nursing, midwifery, and other health-related professions. The IJNS aims to support evidence-informed policy and practice by publishing research, systematic and other scholarly reviews, critical discussion, and commentary of the highest standard. The journal particularly welcomes studies that aim to evaluate and understand complex health care interventions and health policies and employ the most rigorous designs and methods appropriate for the research question of interest. The journal also seeks to advance the quality of research by publishing methodological papers introducing or elaborating on analytic techniques, measures, and research methods. The journal has been publishing original peer-reviewed articles of interest to the international health care community since 1963, making it one of the longest standing repositories of scholarship in this field. The IJNS offers authors the benefits of: A highly respected journal in its field with consistently high impact Indexed in major databases: PubMed, Medline, Thomson Reuters - Science Citation Index, Scopus, Thomson Reuters - Social Science Citation Index, CINAHL, and the BNI (British Nursing Index). A truly global readership Highly efficient editorial processes: average time from submission to first decision of 4 weeks Rapid initial screening for suitability and editorial interest Excellent peer reviewers drawn from a range of health service research disciplines Final online publication as soon as 2 weeks post-acceptance. The IJNS endorses the Equator Network an international initiative that seeks to improve the reliability and value of research literature in health care by promoting transparent and accurate reporting of studies. We ask our authors to make use of appropriate reporting guidelines to ensure excellence in scientific reporting. Authors are also welcome to submit to IJNS's open-access companion title, International Journal of Nursing Studies Advances, which welcomes excellent original research, reviews, and discussion relevant to nursing, midwifery, and other health-related professions around the globe. Abstracting and Indexing Social Sciences Citation Index Science Citation Index Expanded EMCARE Current Contents - Social & Behavioral Sciences Psychology Abstracts PubMed/Medline CINAHL ASSIA Scopus British Nursing Index CISTI CIRRIE

BMC public health Impact Factor 2024-2025 - ResearchHelpDesk - BMC Public Health is an open access, peer-reviewed journal that considers articles on the epidemiology of disease and the understanding of all aspects of public health. The journal has a special focus on the social determinants of health, the environmental, behavioral, and occupational correlates of health and disease, and the impact of health policies, practices and interventions on the community. Indexing Details CABI CAS Current contents Citebase DOAJ EmCare Medscape SOCOLAR Embase Food Science and Technology Abstracts Global Health OAIster MEDLINE PubMed Central PubMed Scopus Science Citation Index Expanded SCImago ​Zetoc

Selective outcome reporting is a significant methodological concern in medicine leading to bias in clinical trial results. Comparisons between the outcomes reported in clinical trial registrations and those later published allow investigators to understand the extent to which selective reporting bias occurs among trialists. The purpose of this study is to examine the possibility of selective outcome reporting in randomized controlled trials (RCTs) published in high impact factor hematology journals. A PubMed search was conducted to identify randomized controlled trials (RCT) published in five hematology journals from 2010-2015. After screening, primary and secondary outcomes were recorded for each trial and then compared with outcomes prespecified in the trial’s registration. Comparisons were made to determine if pre-specified trial registry outcomes were changed in the published reports. Of 113 RCTs, 56 (49.6%) demonstrated major outcome discrepancies between registry and publication, totaling 119 major discrepant outcomes, the majority of which favored a statistically significant result. We found a high rate of discordance between registered and published outcomes in high impact factor hematology journals. In addition, a high proportion of outcome discrepancies favored publication of a statistically significant result, suggesting selective outcome reporting bias.

The data are presented for countries with more than 50 publications.

The evaluation result of the CONSORT checklist.